These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7002821)

  • 1. Hydrophobic interactions in the urokinase active centre. Inhibitory action of alkyl ammonium and amidinium ions: comparison with trypsin.
    Christova E; Yomtova V; Blagoev B
    Int J Pept Protein Res; 1980 May; 15(5):459-63. PubMed ID: 7002821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel binding interactions in the development of potent, selective 2-naphthamidine inhibitors of urokinase. Synthesis, structural analysis, and SAR of N-phenyl amide 6-substitution.
    Wendt MD; Rockway TW; Geyer A; McClellan W; Weitzberg M; Zhao X; Mantei R; Nienaber VL; Stewart K; Klinghofer V; Giranda VL
    J Med Chem; 2004 Jan; 47(2):303-24. PubMed ID: 14711304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.
    Renatus M; Bode W; Huber R; Stürzebecher J; Stubbs MT
    J Med Chem; 1998 Dec; 41(27):5445-56. PubMed ID: 9876114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering bidentate macromolecular inhibitors for trypsin and urokinase-type plasminogen activator.
    Yang SQ; Craik CS
    J Mol Biol; 1998 Jun; 279(4):1001-11. PubMed ID: 9642077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor.
    Towle MJ; Lee A; Maduakor EC; Schwartz CE; Bridges AJ; Littlefield BA
    Cancer Res; 1993 Jun; 53(11):2553-9. PubMed ID: 8495419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetra-p-amidinophenoxy-propane as a probe of the specificity site of serine proteases.
    Menegatti E; Guarneri M; Ferroni R; Bolognesi M; Ascenzi P; Antonini E
    FEBS Lett; 1982 May; 141(1):33-6. PubMed ID: 7044822
    [No Abstract]   [Full Text] [Related]  

  • 7. [Synthetic inhibitors of serine proteinases. 17. The effect of benzamidine derivatives on the activity of urokinase and the reduction of fibrinolysis].
    Stürzebecher J; Markwardt F
    Pharmazie; 1978 Sep; 33(9):599-602. PubMed ID: 733877
    [No Abstract]   [Full Text] [Related]  

  • 8. Aromatic amidines: comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin, and trypsin.
    Tidwell RR; Geratz JD; Dubovi EJ
    J Med Chem; 1983 Feb; 26(2):294-8. PubMed ID: 6219223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent antimalarial activity of 2-aminopyridinium salts, amidines, and guanidines.
    Calas M; Ouattara M; Piquet G; Ziora Z; Bordat Y; Ancelin ML; Escale R; Vial H
    J Med Chem; 2007 Dec; 50(25):6307-15. PubMed ID: 18004799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of trypsin and urokinase by Cbz-amino(4-guanidinophenyl)methanephosphonate aromatic ester derivatives: the influence of the ester group on their biological activity.
    Sieńczyk M; Oleksyszyn J
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2886-90. PubMed ID: 16546384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of trypsin activated by alkylammonium ions and alpha-chymotrypsin.
    Vajda T; Szabó T
    Acta Biochim Biophys Acad Sci Hung; 1973; 8(1):9-22. PubMed ID: 4784864
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the effect of the amidinium group and the phenyl ring on the thermodynamics of binding of benzamidinium chloride to trypsin.
    Talhout R; Engberts JB
    Org Biomol Chem; 2004 Nov; 2(21):3071-4. PubMed ID: 15505709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of netropsin and pentamidine amino analogues on the amidolytic activity of plasmin, trypsin and urokinase.
    Pućkowska A; Midura-Nowaczek K; Bruzgo I
    Acta Pol Pharm; 2008; 65(2):213-5. PubMed ID: 18666427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA).
    West CW; Adler M; Arnaiz D; Chen D; Chu K; Gualtieri G; Ho E; Huwe C; Light D; Phillips G; Pulk R; Sukovich D; Whitlow M; Yuan S; Bryant J
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5712-5. PubMed ID: 19703768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting and designing inhibitor selectivity determinants at the S1 site using an artificial Ala190 protease (Ala190 uPA).
    Katz BA; Luong C; Ho JD; Somoza JR; Gjerstad E; Tang J; Williams SR; Verner E; Mackman RL; Young WB; Sprengeler PA; Chan H; Mortara K; Janc JW; McGrath ME
    J Mol Biol; 2004 Nov; 344(2):527-47. PubMed ID: 15522303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cyclic peptidylic inhibitor of murine urokinase-type plasminogen activator: changing species specificity by substitution of a single residue.
    Andersen LM; Wind T; Hansen HD; Andreasen PA
    Biochem J; 2008 Jun; 412(3):447-57. PubMed ID: 18318660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.
    Ellis V; Whawell SA; Werner F; Deadman JJ
    Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D-QSAR CoMFA studies on trypsin-like serine protease inhibitors: a comparative selectivity analysis.
    Bhongade BA; Gouripur VV; Gadad AK
    Bioorg Med Chem; 2005 Apr; 13(8):2773-82. PubMed ID: 15781388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.